Initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction is related to platelet response to aspirin. 
Introduction
Approximately 10-20% of patients with acute ST-segment elevation myocardial infarction STEMI present themselves with spontaneous coronary recanalization before angioplasty and the prognosis of these patients is significantly better in terms of smaller size of infarction, lower incidence of heart failure, and improved early as well as late survival when compared to patients with persistent occlusion [1] . Platelet-dependent thrombosis plays a crucial role in the occlusion of the infarct-related artery (IRA) in acute MI. It is possible that stronger platelet response to aspirin may influence the tendency to early spontaneous coronary reperfusion in a certain proportion of patients with acute STEMI. The aim of our study was to determine whether patients presenting with higher coronary flow in the IRA at the time of initial angiography differ from patients with persistent occlusion in terms of platelet response to aspirin.
Material and methods
Study population included 70 consecutive patients who underwent primary percutaneous coronary intervention (PCI) for acute STEMI. All patients were using 100 mg of aspirin daily for at least 7 days before admittance. The compliance to aspirin was assessed by interview. Blood samples were collected from antecubital vein before clopidogrel loading and angiography.
Exclusion criteria were: previous treatment with clopidogrel, nonsteroidal anti-inflammatory drugs, heparin and GpIIbIIIa inhibitors, a history of bleeding disorders, platelet count ≤100x10 9 /L, hematocrit ≤0.30 or renal failure (creatinine ≥140 µmol/L). All patients had given informed consent and the study protocol was approved by the local ethics committee.
Platelet function test was done using Multiplate ® ASPI-test. This is the impedance-based «point-of-care» test, where a resistance change between two electrodes immersed into the whole blood is determined after the addition of AA with its final concentration of 0.5 mM [2] . Aggregation is expressed in arbitrary units (U). Platelet reactivity was expressed as interquartile range. Aspirin resistance was defined by an AUC of >31 U (75 th percentile of aggregation in ASPI-test from 110 control patients with stable coronary artery disease taking daily 100 mg of aspirin).
Coronary flow was evaluated quantitatively according to the Thrombolysis In Myocardial
Infarction (TIMI) grading system by two independent interventional cardiologists at the core lab, blinded for aggregation measurements. TIMI-0 is related to complete occlusion of the IRA, TIMI-1 is related to some penetration of contrast beyond the point of obstruction but without perfusion of the distal coronary bed, TIMI-2 is related to perfusion of the entire IRA into the distal coronary bed but with delayed flow compared with a normal artery and TIMI-3 represents full perfusion of IRA with normal flow [3] . values that equaled optimal for our control population (ASPI<31): patients with optimal ASPItest had significantly higher proportion of TIMI-2 or 3 flow than the patients with suboptimal ASPI levels (P=0.004, Table 2 ). 
Discussion
The benefit from aspirin in patients with acute MI has already been ascertained. However it is not known whether this is due to a higher rate of early spontaneous IRA recanalisation. The influence of platelets physiology on early coronary patency has been previously reported. Soluble platelet glycoprotein V as a marker of stronger platelet activation was found to be higher in plasma of patients with acute STEMI and persistent occlusion at initial angiography when compared to those with spontaneous recanalization [4] . Maden et al found that lower admission mean platelet volume was an independent predictor of IRA patency in patients with acute STEMI [5] , although we didn't confirm this in our study. Finally, aspirin effect is heterogeneous and a part of treated patients have suboptimal antiplatelet response, the so called aspirin resistance. There is a substantial body of evidence for its unfavorable role in the development of adverse clinical cardiovascular events [6] .
Our study is the first to examine the relation of platelet aspirin response to the patency of IRA before primary angioplasty in acute STEMI. We had only 6% of patients with initial TIMI-3 flow which is much lower then 16% reported by Stone et al [1] . This can be explained by their definition of TIMI-3 flow, where "complete filling of the distal vessel by the third cardiac cycle" overestimates the proportion of these patients when compared to the original TIMI definition that was used in our study [7] .
Our results indicate that patients with stronger response to aspirin as assessed by AA induced aggregation in ASPI-test have significantly higher initial coronary flow when compared to those with suboptimal platelet response. The limitations of our study are the small size of the study population and lack of objective method, other than patient interview, to ascertain previous usage of aspirin.
